← Back to Search

Behavioural Intervention

Inspiratory Muscle Training (IMT) for Cancer Survivors

N/A
Recruiting
Led By Simon Ho
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Completed medical treatment (chemotherapy, chemotherapy/surgery, chemotherapy/radiation or any combination of cancer treatment) for any type of cancer, except for cancer of the central nervous system, at least 1 year ago
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial aims to see if a specialized breathing muscle training program can help childhood cancer survivors improve how they breathe during exercise.

Who is the study for?
This trial is for childhood cancer survivors who finished treatment (like chemo, surgery, or radiation) at least a year ago. It's not for those who had central nervous system cancers. Participants should be interested in improving their breathing muscles through training.Check my eligibility
What is being tested?
The study tests the POWERbreathe Plus IMT device to see if it helps with breathing muscle strength and how well participants can regulate their breath during exercise after surviving cancer in childhood.See study design
What are the potential side effects?
While specific side effects are not detailed, inspiratory muscle training may cause temporary tiredness of breathing muscles or discomfort due to the effort required during exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I finished my cancer treatment, except for brain cancer, over a year ago.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to treatment protocol
Percent completion
Secondary outcome measures
Diaphragm thickness (measured in mm)
Exercise ventilation
Maximal inspiratory pressure (measured in cm H2O)
Other outcome measures
6-minute walk test distance (measured in m)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Inspiratory Muscle Training (IMT)Experimental Treatment1 Intervention
Participants will be asked to perform inspiratory muscle training (breathing exercise) 5 days per week for 6 weeks at home.

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
688 Previous Clinical Trials
374,643 Total Patients Enrolled
Simon HoPrincipal InvestigatorUniversity of Maryland, Baltimore
1 Previous Clinical Trials
13 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the enrollment criteria for this medical study include individuals who are at least 40 years of age?

"The recruitment for this study includes individuals over 6 years of age but under the age of 12."

Answered by AI

What are the eligibility criteria for individuals seeking to participate in this clinical study?

"The research aims to recruit 13 individuals, who are cancer survivors aged between 6 and 12. Eligible participants must have finished their anti-cancer treatment (chemotherapy, surgery/chemotherapy, radiation/chemotherapy or a mix of treatments) for any type of cancer - except central nervous system cancers - at least one year ago."

Answered by AI

What is the current number of patients being recruited for participation in this medical study?

"Yes, information available on clinicaltrials.gov indicates that this research study is actively seeking individuals to participate. The trial was initially posted on February 1st, 2024, and the most recent update was made on February 6th, 2024. Enrolment aims at recruiting a total of 13 patients from a single designated site."

Answered by AI

Is the enrollment for this research study still ongoing?

"Indeed, as per clinicaltrials.gov data, this trial is actively in search of participants. The study was initially published on February 1st, 2024 and last revised on February 6th, 2024. A total of 13 patients are being sought at a single site for enrollment."

Answered by AI
~9 spots leftby Oct 2024